Related Experiment Video
Updated: May 11, 2026
09:49
Measurement of the Pressure-volume Curve in Mouse Lungs
Published on: January 27, 2015
Longitudinal lung volume changes in patients with chronic obstructive pulmonary disease
Jae Seung Lee1, Seon Ok Kim, Joon Beom Seo
1Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Olympic-ro 43 gil, Sonpa-gu, Seoul, 138-736, South Korea.
Lung
|May 30, 2013
Summary
This study identified key predictors of worsening lung hyperinflation in COPD patients. A higher modified Medical Research Council (MMRC) dyspnea score, increased Charlson comorbidity index, and lower post-bronchodilator FEV1 predict a faster decline in inspiratory capacity to total lung capacity ratio (IC/TLC).
Area of Science:
- Pulmonary Medicine
- Respiratory Physiology
Background:
- Long-term prospective studies on lung hyperinflation progression in COPD are limited.
- Understanding longitudinal changes in lung volumes is crucial for COPD management.
Purpose of the Study:
- To explore longitudinal changes in lung volume compartments in COPD patients.
- To identify predictors of a rapid decline in the inspiratory capacity to total lung capacity ratio (IC/TLC).
Main Methods:
- A prospective cohort of 324 COPD patients was analyzed.
- Annual rates of change in pulmonary function tests (PFTs) were estimated using random coefficient models.
- Key PFTs included FEV1, FVC, TLC, IC, and IC/TLC.
Main Results:
- Significant annual declines were observed in FEV1 (-23.0 mL/year), VC (-33.7 mL/year), IC (-53.9 mL/year), TLC (-43.7 mL/year), and IC/TLC (-0.65%/year).
- Residual volume (RV) and functional residual capacity (FRC) did not change significantly.
- High MMRC dyspnea score, high Charlson comorbidity index, and low post-bronchodilator FEV1 were associated with rapid IC/TLC decline.
Conclusions:
- The modified Medical Research Council (MMRC) dyspnea scale, post-bronchodilator FEV1, and Charlson comorbidity index are independent predictors of rapid IC/TLC decline in COPD.
- These factors can help identify patients at higher risk of lung hyperinflation progression.
Related Concept Videos
01:15Respiratory Volumes
Respiratory volumes are crucial metrics, meticulously measured to quantify the air exchanged in and out of the lungs during various phases of the breathing cycle. These precise measurements are vital for assessing lung function, diagnosing respiratory conditions, and monitoring overall respiratory health. Each parameter provides specific insights into the mechanics of breathing and the functional capacity of the lungs.
Tidal Volume (TV) Tidal volume (TV) is the air inhaled or exhaled in a...
Tidal Volume (TV) Tidal volume (TV) is the air inhaled or exhaled in a...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:47Lung Capacity
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.